Press Releases

Transplant Diagnostic Market is Projected to Surpass US$ 1,289.3 Mn by 2030

The global transplant diagnostic market was valued at US$ 730.9 Mn in 2017 and is projected to surpass US$ 1,289.3 Mn by 2026, expanding at a compound annual growth rate (CAGR) of more than 6.5% from 2018 to 2030.

Transplant Diagnostic Market – Snapshot

The global transplant diagnostic market is expanding due to the increasing number of patients emphasizing on early patient profiling during organ transplantation and rising adoption of transplant diagnostic techniques. The global market is expanding at a relatively higher growth rate owing to increasing bone marrow transplantation practices, high incidences of pediatric transplantation surgery, occurrence of kidney disorder among geriatric population, and increasing clinical evidence to establish clinical efficacy of molecular assay technique.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111990 

Transplant diagnostic is an administrative as well as clinical tool that helps improve operational efficiency of transplantation technique. Transplant diagnostic aids the patients suffering from cancer in order to improve overall operational efficiency as well as patient care. High prevalence and incidence rates of kidney dysfunction, cardiac diseases, increase in number of cases of lungs disorder and orthopedic injuries in the global population has led to the increase in patient flow to private clinics and hospitals. These factors, collectively, are projected to drive the demand for transplant diagnostic in the near future. Furthermore, the compatibility of markers increases the probability of graft survival and decreases severe immunologic transplant complications, which in turn is estimated to fuel the transplant diagnostic market in the near future.

The global transplant diagnostic market has been broadly segmented based on screening, technique, product & services, application, end-user, and region. In terms of application, the global market has been categorized into stem cell transplantation and solid organ transplantation. The solid organ transplantation segment has been further sub-segmented into kidney, liver, heart, lungs, pancreas, and small bowel. The kidney transplant sub-segment accounted for a key share of the solid organ transplantation segment, in terms of revenue, of the global market in 2017. The liver sub-segment is estimated to expand at a prominent growth rate during the forecast period, and the sub-segment is estimated to report significant gain in market share by the end of 2026. Liver transplant diagnostic is increasingly gaining popularity among cancer patients and physicians, which is also a major factor that is estimated to drive the liver sub-segment between 2018 and 2026.

In terms of technique, the global transplant diagnostic has been classified into molecular assay and non-molecular assay. The non-molecular assay segment dominated the global market and is likely to maintain its dominance by the end of 2026 with marginal increase in its year-on-year growth rate. Rapid advances in the fields of transplant medicine and cancer treatment and the ever-growing implementation of immunomodulatory regimens led to significant increase in the prevalence and prolonged survival of people in immunocompromised states. These are key factors which have led the non-molecular assay segment to hold a prominent share of the global market. Based on screening, the transplant diagnostic market has been bifurcated into pre-transplant diagnostic and post-transplant diagnostic. In terms of product & services, the transplant diagnostic market has been split into reagents & consumables, instruments, and software. Based on end-user, the global market has been segregated into hospital & transplant centers, research laboratories, and others.

View full report@ https://qyresearchmedical.com/report/transplant-diagnostic-market-screening-pre-transplant-diagnostic-post-transplant-diagnostic-technique-molecular-assay-non-molecular-assay-application-stem-cell-transplantation-solid-organ-transplantation-018-2030/111990

In terms of region, the global transplant diagnostic market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2026. The market in North America is primarily driven by the rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. Moreover, increasing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is projected to fuel the transplant diagnostic market in the U.S. during the forecast period. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. China dominated the transplant diagnostic market in Asia Pacific, whereas the market in India is estimated to expand at a significant CAGR during the forecast period.

Companies such as Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., and Becton, Dickinson and Company accounted for a major share of the global transplant diagnostic market in 2017 In July 2017, Thermo Fisher Scientific acquired Linkage Biosciences. Linkage Biosciences is presently a part of Thermo Fisher’s transplant diagnostics business. Through this acquisition, Thermo Fisher currently provides services to more than 1,000 transplant centres in more than 60 countries. Other global players operating in the market include Ortho Clinical Diagnostics (a part of Carlyle Group), Immucor, Inc., Illumina, Inc., Siemens Healthineers (Siemens AG), and Agilent Technologies. Companies are adopting the strategy of acquisition and collaboration with parallel companies in order to improve and strengthen its geographic presence in the global market.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111990/2900

The global transplant diagnostic market has been segmented as given below:

Screening

  • Pre-Transplant Diagnostic
  • Post-Transplant Diagnostic

Technique

  • Molecular Assay
  • Non-Molecular Assay

Application

  • Solid Organ Transplantation
  • Kidney
  • Liver
  • Heart
  • Lungs
  • Pancreas
  • Small Bowel
  • Stem Cell Transplantation

Product & Services

  • Reagents & Consumables
  • Instruments
  • Software & Services

End-user

  • Hospitals
  • Clinics
  • Rehab centers
  • Others

Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

TABLE OF CONTENT

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Transplant Diagnostic Market

4. Market Overview
4.1. Introduction
4.1.1. Technique Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.3.4. Trends
4.4. Global Transplant Diagnostic Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Market Outlook
4.6.Regulatory Scenarios
4.7. Number of Transplantations, by Region/Country
4.8. Key Success Factors of Top 3 Companies

5. Global Transplant Diagnostic Market Analysis and Forecast, by Technique
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Global Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
5.3.1. Molecular Assay
5.3.2. Non-Molecular Assay
5.4. Market Attractiveness, by Technique

6. Global Transplant Diagnostic Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
6.3.1. Solid Organ Transplantation
6.3.1.1. Kidney
6.3.1.2. Liver
6.3.1.3. Heart
6.3.1.4. Lungs
6.3.1.5. Pancreas
6.3.1.6. Small Bowel
6.3.2. Stem Cell Transplantation
6.4. Market Attractiveness, by Application

7. Global Transplant Diagnostic Market Analysis and Forecast, by Screening
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
7.3.1. Pre-Transplant Diagnostic
7.3.2. Post-Transplant Diagnostic
7.3.3. Instruments
7.4. Market Attractiveness, by Screening

8. Global Transplant Diagnostic Market Analysis and Forecast, by Product & Services
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
8.3.1. Reagents & Consumables
8.3.2. Instruments
8.3.3. Software & Services
8.4. Market Attractiveness, by Product & Services

9. Global Transplant Diagnostic Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospital & Transplant Centers
9.3.2. Research Laboratories
9.3.3. Others
9.4. Market Attractiveness, by End-user

10. Global Transplant Diagnostic Market Analysis and Forecast, by Region
10.1.Key Findings
10.2. Global Transplant Diagnostic Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3.Market Attractiveness, by Country/Region

11. North America Transplant Diagnostic Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. North America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
11.2.1. Molecular Assay
11.2.2. Non-Molecular Assay
11.3. North America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
11.3.1. Solid Organ Transplantation
11.3.1.1. Kidney
11.3.1.2. Liver
11.3.1.3. Heart
11.3.1.4. Lungs
11.3.1.5. Pancreas
11.3.1.6. Small Bowel
11.3.2. Stem Cell Transplantation
11.4. North America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
11.4.1. Pre-Transplant Diagnostic
11.4.2. Post-Transplant Diagnostic
11.4.3. Instruments
11.5. North America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
11.5.1. Reagents & Consumables
11.5.2. Instruments
11.5.3. Software & Services
11.6. North America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
11.6.1. Hospital & Transplant Centers
11.6.2. Research Laboratories
11.6.3. Others
11.7. North America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
11.7.1. U.S.
11.7.2. Canada
11.8. North America Transplant Diagnostic Market Attractiveness Analysis
11.8.1. By Technique
11.8.2. By Application
11.8.3. By Screening
11.8.4. By Product & Services
11.8.5. By End-user
11.8.6. By Country

12. Europe Transplant Diagnostic Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Europe Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
12.2.1. Molecular Assay
12.2.2. Non-Molecular Assay
12.3. Europe Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
12.3.1. Solid Organ Transplantation
12.3.1.1. Kidney
12.3.1.2. Liver
12.3.1.3. Heart
12.3.1.4. Lungs
12.3.1.5. Pancreas
12.3.1.6. Small Bowel
12.3.2. Stem Cell Transplantation
12.4. Europe Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
12.4.1. Pre-Transplant Diagnostic
12.4.2. Post-Transplant Diagnostic
12.4.3. Instruments
12.5. Europe Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
12.5.1. Reagents & Consumables
12.5.2. Instruments
12.5.3. Software & Services
12.6. Europe Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
12.6.1. Hospital & Transplant Centers
12.6.2. Research Laboratories
12.6.3. Others
12.7. Europe Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
12.7.1. Germany
12.7.2. U.K.
12.7.3. France
12.7.4. Spain
12.7.5. Italy
12.7.6. Rest of Europe
12.8. Europe Transplant Diagnostic Market Attractiveness Analysis
12.8.1. By Technique
12.8.2. By Application
12.8.3. By Screening
12.8.4. By Product & Services
12.8.5. By End-user
12.8.6. By Country

13. Asia Pacific Transplant Diagnostic Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Asia Pacific Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
13.2.1. Molecular Assay
13.2.2. Non-Molecular Assay
13.3. Asia Pacific Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
13.3.1. Solid Organ Transplantation
13.3.1.1. Kidney
13.3.1.2. Liver
13.3.1.3. Heart
13.3.1.4. Lungs
13.3.1.5. Pancreas
13.3.1.6. Small Bowel
13.3.2. Stem Cell Transplantation
13.4. Asia Pacific Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
13.4.1. Pre-Transplant Diagnostic
13.4.2. Post-Transplant Diagnostic
13.4.3. Instruments
13.5. Asia Pacific Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
13.5.1. Reagents & Consumables
13.5.2. Instruments
13.5.3. Software & Services
13.6. Asia Pacific Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
13.6.1. Hospital & Transplant Centers
13.6.2. Research Laboratories
13.6.3. Others
13.7. Asia Pacific Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
13.7.1. China
13.7.2. Japan
13.7.3. India
13.7.4. Australia & New Zealand
13.7.5. Rest of Asia Pacific
13.8. Asia Pacific Transplant Diagnostic Market Attractiveness Analysis
13.8.1. By Technique
13.8.2. By Application
13.8.3. By Screening
13.8.4. By Product & Services
13.8.5. By End-user
13.8.6. By Country

14. Latin America Transplant Diagnostic Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Latin America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
14.2.1. Molecular Assay
14.2.2. Non-Molecular Assay
14.3. Latin America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
14.3.1. Solid Organ Transplantation
14.3.1.1. Kidney
14.3.1.2. Liver
14.3.1.3. Heart
14.3.1.4. Lungs
14.3.1.5. Pancreas
14.3.1.6. Small Bowel
14.3.2. Stem Cell Transplantation
14.4. Latin America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
14.4.1. Pre-Transplant Diagnostic
14.4.2. Post-Transplant Diagnostic
14.4.3. Instruments
14.5. Latin America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
14.5.1. Reagents & Consumables
14.5.2. Instruments
14.5.3. Software & Services
14.6. Latin America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
14.6.1. Hospital & Transplant Centers
14.6.2. Research Laboratories
14.6.3. Others
14.7. Latin America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Latin America Transplant Diagnostic Market Attractiveness Analysis
14.8.1. By Technique
14.8.2. By Application
14.8.3. By Screening
14.8.4. By Product & Services
14.8.5. By End-user
14.8.6. By Country

15. Middle East & Africa Transplant Diagnostic Market Analysis and Forecast
15.1.Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
15.2.1. Molecular Assay
15.2.2. Non-Molecular Assay
15.3. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
15.3.1. Solid Organ Transplantation
15.3.1.1. Kidney
15.3.1.2. Liver
15.3.1.3. Heart
15.3.1.4. Lungs
15.3.1.5. Pancreas
15.3.1.6. Small Bowel
15.3.2. Stem Cell Transplantation
15.4. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
15.4.1. Pre-Transplant Diagnostic
15.4.2. Post-Transplant Diagnostic
15.4.3. Instruments
15.5. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
15.5.1. Reagents & Consumables
15.5.2. Instruments
15.5.3. Software & Services
15.6. Middle East & Africa Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
15.6.1. Hospital & Transplant Centers
15.6.2. Research Laboratories
15.6.3. Others
15.7. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
15.7.1. GCC countries
15.7.2. South Africa
15.7.3. Israel
15.7.4. Rest of Middle East & Africa
15.8. Middle East & Africa Transplant Diagnostic Market Attractiveness Analysis
15.8.1. By Technique
15.8.2. By Application
15.8.3. By Screening
15.8.4. By Product & Services
15.8.5. By End-user
15.8.6. By Country

16. Competition Landscape
16.1.Market Player – Competition Matrix (by Tier and Size of companies)
16.2.Market Share Analysis by Company (2017)
16.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
16.3.1. Bio-Rad Laboratories, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Financial Overview
16.3.1.5. Strategic Overview
16.3.2. Qiagen N.V.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Financial Overview
16.3.2.5. Strategic Overview
16.3.3. F. Hoffmann-La Roche AG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Financial Overview
16.3.3.5. Strategic Overview
16.3.4. Thermo Fisher Scientific, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Financial Overview
16.3.4.5. Strategic Overview
16.3.5. Becton, Dickinson and Company
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Financial Overview
16.3.5.5. Strategic Overview
16.3.6. Ortho Clinical Diagnostics
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Financial Overview
16.3.6.5. Strategic Overview
16.3.7. Immucor, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Financial Overview
16.3.7.5. Strategic Overview
16.3.8. Illumina, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Financial Overview
16.3.8.5. Strategic Overview
16.3.9. Siemens Healthineers (Siemens AG)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Financial Overview
16.3.9.5. Strategic Overview
16.3.10. Agilent Technologies
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Financial Overview
16.3.10.5. Strategic Overview
16.3.11. Others

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111990/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Show More

Related Articles

Check Also
Close
Back to top button